These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11861507

  • 1. The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells.
    Klinge CM, Jernigan SC, Risinger KE.
    Endocrinology; 2002 Mar; 143(3):853-67. PubMed ID: 11861507
    [Abstract] [Full Text] [Related]

  • 2. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM.
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM.
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [Abstract] [Full Text] [Related]

  • 5. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
    Shah YM, Rowan BG.
    Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
    [Abstract] [Full Text] [Related]

  • 6. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
    Ramsey TL, Risinger KE, Jernigan SC, Mattingly KA, Klinge CM.
    Endocrinology; 2004 Jan; 145(1):149-60. PubMed ID: 14500565
    [Abstract] [Full Text] [Related]

  • 7. Estrogenic activity in white and red wine extracts.
    Klinge CM, Risinger KE, Watts MB, Beck V, Eder R, Jungbauer A.
    J Agric Food Chem; 2003 Mar 26; 51(7):1850-7. PubMed ID: 12643641
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner).
    Seol W, Hanstein B, Brown M, Moore DD.
    Mol Endocrinol; 1998 Oct 26; 12(10):1551-7. PubMed ID: 9773978
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA.
    Mol Endocrinol; 1999 Mar 26; 13(3):418-30. PubMed ID: 10076999
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 12. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2007 May 17; 104(3-5):110-22. PubMed ID: 17478088
    [Abstract] [Full Text] [Related]

  • 13. Nongenomic activity and subsequent c-fos induction by estrogen receptor ligands are not sufficient to promote deoxyribonucleic acid synthesis in human endometrial adenocarcinoma cells.
    Singleton DW, Feng Y, Burd CJ, Khan SA.
    Endocrinology; 2003 Jan 17; 144(1):121-8. PubMed ID: 12488337
    [Abstract] [Full Text] [Related]

  • 14. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Guzmán CB, Deighton-Collins S, Martinez A, Kleerekoper M, Zhao C, Benjamins JA, Skafar DF.
    Neuro Endocrinol Lett; 2005 Oct 17; 26(5):526-32. PubMed ID: 16264406
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D, Dardes R, Liu H, MacGregor-Schafer J, Zapf J, Jordan V.
    Endocrinology; 2001 Feb 01; 142(2):838-46. PubMed ID: 11159857
    [Abstract] [Full Text] [Related]

  • 19. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
    Biswas DK, Averboukh L, Sheng S, Martin K, Ewaniuk DS, Jawde TF, Wang F, Pardee AB.
    Mol Med; 1998 Jul 01; 4(7):454-67. PubMed ID: 9713824
    [Abstract] [Full Text] [Related]

  • 20. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta.
    Watanabe T, Inoue S, Ogawa S, Ishii Y, Hiroi H, Ikeda K, Orimo A, Muramatsu M.
    Biochem Biophys Res Commun; 1997 Jul 09; 236(1):140-5. PubMed ID: 9223441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.